Quantum BioPharma Ltd. recently expanded its cryptocurrency holdings, bringing total investments to $3.5 million. This decision aligns with broader trends in the biotech sector.
Quantum BioPharma Increasing Crypto Assets
The company purchased $1.5 million worth of cryptocurrencies, including Bitcoin, to hedge against inflation and diversify financial strategies.
Bitcoin’s Trading Value Sparks Market Discussion
Bitcoin trades at $84,721, indicating volatility. Analysts suggest cryptocurrencies help hedge against market risks.
Companies Following ATAI’s Lead
Since 2021, ATAI Life Sciences has been holding Bitcoin, starting a trend among biotech companies. According to Christian Angermayer, cryptocurrency allocation aids in maintaining financial stability.
Quantum BioPharma and other biotech companies increasingly use cryptocurrencies for diversification and business resilience.